Skip to Content

ML P19 8 mg (Doxazosin 8 mg)

Pill imprint ML P19 8 mg has been identified as Doxazosin mesylate 8 mg.

Doxazosin is used in the treatment of benign prostatic hyperplasia; high blood pressure; raynaud's syndrome and belongs to the drug class antiadrenergic agents, peripherally acting. Risk cannot be ruled out during pregnancy. Doxazosin 8 mg is not a controlled substance under the Controlled Substance Act (CSA).

Doxazosin mesylate 8 mg ML P19 8 mg
Doxazosin mesylate 8 mg ML P19 8 mg
Discount Card Promo
Doxazosin mesylate
ML P19 8 mg
8 mg
Elliptical / Oval
Prescription only
Drug Class:
Antiadrenergic agents, peripherally acting
Pregnancy Category:
C - Risk cannot be ruled out
CSA Schedule:
Not a controlled drug
Dava Pharmaceuticals Inc.
National Drug Code (NDC):
Inactive Ingredients:
microcrystalline cellulose
magnesium stearate
sodium lauryl sulfate
FD&C Blue No. 2
D&C Yellow No. 10
aluminum oxide

More info Print Imprint Search

Disclaimer: Every effort has been made to ensure that the information provided is accurate, up-to-date, and complete, but no guarantee is made to that effect. If you have questions about the drugs you are taking, check with your doctor, nurse or pharmacist.

Copyright 2016, National Library of Medicine, Truven Health Analytics and Cerner Multum, Inc. All Rights Reserved.